Top ▲
Ligand name | ID | Synonyms | |||||||
A | Back to top | ||||||||
A-71378 | 894 | A 71378, A71378 | |||||||
A-71623 | 858 | A 71623, A71623, L-phenylalaninamide | |||||||
A-71915 | 4856 | A 71915, A71915, H-3048 | |||||||
A8Δ71-73 | 5780 | ||||||||
abaloparatide | 8299 | BA058, Tymlos® | |||||||
abarelix | 1188 | Plenaxis®, PPI 149, R 3827 | |||||||
abatacept | 6891 | BMS-188667, CTLA4-IgG4m, Orencia®, RG-1046, RG-2077 | |||||||
A(4-24)(B7-24)H2 | 8346 | A(4-24)(B7-24)H2 relaxin | |||||||
A(4-24)(B7-24)H2 chain A | 8347 | A(4-24)H2 relaxin | |||||||
A(4-24)(B7-24)H2 chain B | 8348 | (B7-24)H2 relaxin | |||||||
abicipar pegol | 8371 | AGN-150998, MP0112 | |||||||
ABS-201 | 5308 | ABS 201, ABS201, HPI-201, HPI201, KK13 | |||||||
ABS-212 | 5307 | ABS 212, ABS212 | |||||||
Abz-Ser-Pro-Tyr(NO2)-OH | 5132 | o-aminobenzoyl-Ser-Pro-Tyr(NO2)-OH, TBC5182 | |||||||
AC-178,335 | 2065 | AC 178335 | |||||||
AC187 | 689 | AC 187, AC-187, acetyl-(Asn30,Tyr32)-calcitonin8-32, salmon calcitonin (8-32) reduced | |||||||
Ac-c[Cys-Glu-His-D-Phe-Arg-Trp-D-Cys]-Pro-Pro-Lys-Asp-NH2 | 1342 | ||||||||
Ac-[13C,15N]PGP | 12599 | ||||||||
[Ac-D-2Nal1,D4CPA2,D-3Pal3,6,Leu8, D-Ala10]GnRH-II | 5583 | ||||||||
Ac-GRP-(20-26)-methylester | 625 | N-acetyl-GRP-(20-26)-ethylester | |||||||
[Ac-His1]PACAP-27 | 2263 | [Ac-His1]pituitary adenylate cyclase activating polypeptide-27 | |||||||
[125I][Ac-His1]PACAP-27 | 2260 | [125I]-[Ac-His1]pituitary adenylate cyclase activating polypeptide-27 | |||||||
Ac-hMCH-(6-16)-NH2 | 1290 | hAc-MCH(6-16)-NH2, human Ac-MCH6-16-NH2 | |||||||
A(Δ10/15C)INSL3 | 8332 | ||||||||
aclerastide | 8300 | DSC-127, DSC127, NorLeu3-A(1-7) | |||||||
Ac-Lys-[MeAla6,Leu8,des-Arg9]bradykinin | 651 | N-acetylated-[Lys,MeAla6,Leu8,des-Arg9]bradykinin, Ac-[MeAla6,Leu8,des-Arg9]kallidin | |||||||
AcPhe-Orn-Pro-D-Cha-Trp-Arg | 3853 | AcF[OP-D-Cha-Wr] | |||||||
Ac-Phe-Trp-Ala-His(τBZL)-Nip-Gly-Arg-NH2 | 6191 | ||||||||
Ac-RHYPLWR | 8380 | ||||||||
Ac-RYYRIK-NH2 | 1679 | ||||||||
Ac-RYYRWK-NH2 | 1680 | ||||||||
Ac-SDKP | 10060 | goralatide, seraspenide | |||||||
A(C10/15S)INSL3 | 8331 | ||||||||
ACTH-(11-24) | 1332 | ACTH (11-24), adrenocorticotropic hormone (11-24) | |||||||
ACTH-(1-24) | 1330 | ACTH (1-24), adrenocorticotropic hormone (1-24) | |||||||
[125I]ACTH-(1-24) | 3767 | [125I]-ACTH(1-24), [125I]-adrenocorticotropin(1-24) | |||||||
[Ac-Tyr1, D-Arg2]GHRH-(1-29)-NH2 (human) | 1125 | ||||||||
adaptavir | 11692 | D-Ala-peptide T-amide, DAPTA | |||||||
AF12198 | 4861 | AF 12198, AF-12198 | |||||||
A(4-24)(F23A)H2 | 8349 | ||||||||
afamelanotide | 1324 | α-NDP-MSH, [Nle4,dPhe7]α-MSH, CUV-1647, CUV1647, NDP-MSH, Scenesse® | |||||||
aflibercept | 6786 | AVE0005, Eylea®, VEGF Trap, Zaltrap®, ziv-aflibercept | |||||||
AFT-II | 2613 | neurotoxin-2, Toxin AFII, Toxin AFT-II | |||||||
ω-agatoxin IIIA | 2528 | omega-Aga-IIIA, Omega-agatoxin-Aa3a | |||||||
ω-agatoxin IVA | 2529 | omega-Aga-IVA, Omega-agatoxin-Aa4a | |||||||
ω-agatoxin IVB | 2530 | Omega-agatoxin-Aa4b | |||||||
A(10-24)INSL3 | 8330 | ||||||||
A(9-26)INSL3 | 8329 | ||||||||
AL-78898A | 9219 | 4(1MeW), POT-4 | |||||||
[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]PTH-(1-34)-NH2 | 5573 | [Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]-hPTH 1-34-NH2, M-PTH(1-34) | |||||||
[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]PTH-(1-21)-NH2 (human) | 5575 | [Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]hPTH-(1-21)-NH2, [Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]-PTH 1-21-NH2 (human), M-PTH(1-21) | |||||||
[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]PTH-(1-28)-NH2 (human) | 5574 | [Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]-hPTH 1-28-NH2, [Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]-PTH 1-28-NH2 (human), M-PTH(1-28) | |||||||
[Ala1,12,Aib3,Gln10,hArg11,Trp14]PTH-(1-14)-NH2 | 5576 | [Ala1,12,Aib3,Gln10,hArg11,Trp14]-hPTH 1-14-NH2, [Ala1,12,Aib3,Gln10,hArg11,Trp14]-PTH 1-14-NH2 (human), M-PTH(1-14) | |||||||
[Ala31,Aib32]NPY | 1560 | ||||||||
[Ala31,Aib32]NPY (pig) | 1522 | ||||||||
[Ala11, D-Leu15]orexin-B | 1700 | ||||||||
[Ala6, D-Trp8]galanin-(1-15)-ol | 6146 | ||||||||
[Ala1,3,11,15]ET-1 | 3837 | [Ala1,3,11,15]endothelin-1 | |||||||
[125I][Ala1,3,11,15]ET-1 | 3760 | [125I]-[Ala1,3,11,15]endothelin-1, [125I][Ala1,3,11,15]endothelin-1 | |||||||
alafosfalin | 9503 | alaphosphin | |||||||
[2Ala]-galparan | 6098 | ||||||||
β-Ala-Lys-AMCA | 9501 | β-alanyl-lysyl-N-7-amino-4-methylcoumarin-3-acetic acid, Beta-Ala-Lys-N(epsilon)-AMCA | |||||||
[βAla8]neurokinin A-(4-10) | 2112 | [βAla8]neurokinin A (4-10) | |||||||
alarelin | 9342 | ||||||||
[Ala11,22,28]VIP | 2278 | [Ala11,22,28]vasoactive intestinal peptide | |||||||
albiglutide | 7386 | Eperzan®, GSK716155, Tanzeum® | |||||||
albutensin A | 10226 | ||||||||
aldafermin | 11546 | M70, NGM-282, NGM282 | |||||||
alefacept | 6787 | Amevive®, BG 9273, BG 9712, BG-9273, BG-9712, Lfa3Tip | |||||||
alglucosidase alfa | 7561 | Lumizyme®, Myozyme®, rhGAA | |||||||
ALM201 | 11485 | ||||||||
alpha1-proteinase inhibitor | 7487 | A1AT, A1PI, alpha 1-antitrypsin, Aralast®, Prolastin®, serum trypsin inhibitor | |||||||
AlprolixTM | 7373 | ||||||||
alunacedase alfa | 11320 | APN01, GSK-2586881, GSK2586881, rhsACE2 | |||||||
ALX40-4C | 607 | ALX 40-4C, N-alpha-acetyl-nona-D-arginine amide acetate | |||||||
AM3 | 5635 | DOTA-Tyr-cyclo(DAB-Arg-cyclo(Cys-Phe-D-Trp-Lys-Thr-Cys) | |||||||
AM-6120 | 10119 | AM6120, peptide 41 [PMID: 30346167] | |||||||
amanitin | 4632 | α-amanitin | |||||||
AMG3054 | 9587 | ||||||||
AM-(22-52) (human) | 706 | AM (22-52), human adrenomedullin (22-52) | |||||||
AM-(11-50) (rat) | 704 | AM (11-50), rat adrenomedullin (11-50) | |||||||
AM-(20-50) (rat) | 705 | rat adrenomedullin (20-50) | |||||||
[125I]AM (rat) | 3768 | [125I]-adrenomedullin, [125I]-AM | |||||||
AMT-101 | 11645 | ||||||||
AMY-101 | 11986 | AMY101, Compstatin 40, Compstatin analog CP40, CP-40, peptide 14 [PMID: 22795972] | |||||||
amyloid β1-16 | 13243 | Aβ(1-16), N-Aβ | |||||||
anakinra | 6972 | antril, Kineret® | |||||||
analog 30 [PMID:18543899] | 5647 | ||||||||
analog 31 [PMID:18543899] | 5648 | ||||||||
analog 32 [PMID:18543899] | 7763 | ||||||||
analog 3 [PMID:18543899] | 5646 | ||||||||
analogue 13: B7-24 | 11918 | ||||||||
anantin | 4866 | ||||||||
andexanet alfa | 7576 | Andexxa®, coagulation factor Xa (recombinant), inactivated-zhzo, Ondexxya®, PRT064445, PRT4445, r-antidote | |||||||
[125I]angiotensin-(1-7) (human, mouse, rat) | 5578 | [125I]ang-(1-7) | |||||||
[125I]ANP (human) | 4845 | [125I]-ANP | |||||||
antarelix | 1189 | D-23234, EP 24332 | |||||||
antisauvagine | 931 | [dPhe11,His12]Svg(11-40), antisauvagine-30 | |||||||
[125I]antisauvagine | 930 | ||||||||
AP811 | 4870 | AP 811, AP-811 | |||||||
apamin | 2311 | ||||||||
[125I]apelin-13 | 602 | ||||||||
apelin-13(F13A) | 5354 | ||||||||
APETx-1 | 2609 | Toxin APETx1 | |||||||
APETx2 | 4135 | ||||||||
aponermin | 13293 | Shaite® (China) | |||||||
apraglutide | 10685 | CVQ1IAY2G6, FE 203799, FE203799 | |||||||
aprotinin {Sp: Bovine} | 6570 | basic protease inhibitor (BPI), BPTI, pancreatic trypsin inhibitor, Trasylol® | |||||||
AR305352 | 7043 | ||||||||
[Arg16]chicken secretin | 3293 | [R16]chicken secretin | |||||||
arginine vasotocin | 2169 | AVT, [Arg8]vasotocin | |||||||
[Arg14Lys15]N/OFQ | 1689 | [Arg14Lys15]nociceptin, [Arg14Lys15]nociceptin/orphanin FQ, [Arg14Lys15]orphanin FQ | |||||||
[Arg19]PTH-(1-34) (human) | 1792 | [Arg19]-PTH 1-34 (human) | |||||||
ARL-15849 | 859 | AR-R 15849, ARL 15849XX, FPL 15849 | |||||||
ASIP [90-132 (L89Y)] | 1327 | agouti-signaling protein [90-132 (L89Y)], agouti-signaling protein[90-132 (L89Y)] | |||||||
astressin | 925 | ||||||||
[125I]astressin | 924 | ||||||||
astressin 2B | 10335 | Astressin2-B, astressin2-B, cyclo(31-34)[DPhe(11),His(12),C(alpha)MeLeu(13,39),Nle(17),Glu(31),Lys(34)]Ac-sauvagine(8-40), peptide 20 [PMID: 12361401] | |||||||
[Asu7,23']β-ANP-(7-28) | 4852 | [Asu7,23']-β-ANP7-28 | |||||||
atacicept | 9517 | TACI-Fc, TACI-Ig | |||||||
atosiban | 2213 | Antocin®, d[D-Tyr(Et)2,Thr4,Orn8]vasotocin, d[D-Tyr(Et)2,Thr4]OVT, ORF22164, RWJ 22164, Tractocile® | |||||||
ATX-II | 2614 | anemonia viridis toxin 2, Sea anemone toxin II (Anemonia sulcata), toxin ATX-II | |||||||
aTyr 1940 | 8738 | ATYR1940, HRS(1-506), Resolaris | |||||||
AUNP-12 | 10117 | Aur-012, Aurigene NP-12, Aurigene-012, compound #8 [WO2011161699A3] | |||||||
Ava3 | 3855 | ||||||||
Ava5 | 3856 | ||||||||
[Ava9,10,Ava14,15]-Ac-hMCH6-16-NH2 | 1307 | compound 30 [PMID:12009900] | |||||||
avexitide | 13444 | ||||||||
aviptadil | 10891 | Invicorp® (aviptadil + phentolamine), Vasoactive intestinal octacosapeptide | |||||||
[3H]AVP (human, mouse, rat) | 2175 | [3H]arginine vasopressin | |||||||
AY77 | 9455 | compound 14 [PMID: 26819675] | |||||||
AYPGKF-NH2 | 4061 | AY-NH2 | |||||||
azapro-3 | 9221 | ||||||||
B | Back to top | ||||||||
B-10356 | 652 | ||||||||
B1-27 | 11459 | analog 2 [PMID: 32133341] | |||||||
B-9430 | 653 | B 9430, B9430, D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin | |||||||
B-9858 | 654 | B 9858, Lys-Lys-[Hyp3, Igl5, D-Igl7, Oic8]des-Arg9-BK | |||||||
B-9958 | 655 | B9958, des-Arg(9)-BK | |||||||
balixafortide | 11587 | POL-6326, POL6326 | |||||||
barusiban | 10890 | C4.6,S1-cyclo[N-(3-sulfanylpropanoyl)-D-tryptophyl-L-isoleucyl-L-alloisoleucyl-L-asparaginyl-L-2-aminobutanoyl-N-methyl-L-ornithinol], FE 200 440, FE-200440 | |||||||
BASS antagonist | 5644 | BASS antagonist Analog 4 | |||||||
BAY 55-9837 | 2269 | ||||||||
BAY86-7548 | 11260 | [68Ga]D-Phe6, Stat13, Leu14 Bn(6-14), [68Ga]RM2, Ga-RM2 | |||||||
[125I]BAY 55-9837 | 2281 | ||||||||
BBL-454 | 895 | BBL 454, BBL454 | |||||||
BC-254 | 896 | BC 254, BC254 | |||||||
BC-264 | 897 | BC 264, BC264 | |||||||
Bc-III | 2615 | major neurotoxin BcIII | |||||||
BCY15291 | 12820 | ||||||||
[125I]BDNF (human) | 4846 | [125I]-BDNF, [125I]-brain-derived neurotrophic factor | |||||||
beinaglutide | 12863 | Feisumei® | |||||||
BeKm-1 | 2610 | neurotoxin BeKm-1, potassium channel toxin γ-KTx 2.1 | |||||||
belatacept | 6892 | BMS-224818, LEA29Y, Nulojix® | |||||||
bempegaldesleukin | 10659 | NKTR-214, NKTR214 | |||||||
bevemipretide | 13258 | SBT-272, SBT272 | |||||||
BgK | 2551 | Potassium channel toxin Bgk | |||||||
[125I]BgK (W5Y / Y26F) | 2565 | ||||||||
(B7-33)H2 | 9321 | ||||||||
[125I]BH-AMY (rat, mouse) | 3770 | [125I]-BH-AMY, [125I]-Bolton Hunter amylin | |||||||
[125I]BH-MIT1 | 8522 | ||||||||
[125I]BH-NMB (human, mouse, rat) | 3771 | [125I]-BH-NMB, [125I]-Bolton Hunter neuromedin B | |||||||
[125I]BH-[Sar9,Met(O2)11]SP | 3769 | [125I]-BH-[Sar9,Met(O2)11]SP, [125I]-Bolton Hunter-[Sar9,Met(O2)11]substance P | |||||||
[3H]BH-[Sar9,Met(O2)11]SP | 3811 | [3H]-Bolton Hunter-[Sar9,Met(O2)11]substance P, [3H]-BH-[Sar9,Met(O2)11]SP | |||||||
bihelical apoA-I mimetic peptide 5A | 9183 | 5A peptide | |||||||
BIM 23023 | 2032 | ||||||||
BIM 23027 | 2033 | BIM23027 | |||||||
BIM 23030 | 2034 | ||||||||
BIM 23034 | 2035 | DC 13-212 | |||||||
BIM 23050 | 2003 | BIM-23050 | |||||||
BIM 23052 | 2004 | BIM-23052, BIM23052, DC-(23-99) | |||||||
BIM 23056 | 2036 | ||||||||
BIM 23058 | 2068 | ||||||||
BIM 23059 | 2037 | ||||||||
BIM 23060 | 2038 | ||||||||
BIM 23066 | 2039 | ||||||||
BIM 23068 | 2040 | ||||||||
BIM 23127 | 2162 | ||||||||
BIM 23197 | 2041 | ||||||||
BIM 23268 | 2083 | BIM23268 | |||||||
BIM 23295 | 2069 | ||||||||
BIM 23313 | 2084 | ||||||||
BIM 23454 | 2026 | ||||||||
BIM 23627 | 2027 | H-5886, MW 1164 | |||||||
BIM28011 | 3857 | [D-Ala2,Ala8,9,15,27,D-Arg29]hGHRH(1-29)NH2, BIM 28011 | |||||||
BIM 28163 | 1101 | BIM-28163 | |||||||
[125I]BIM23027 | 3772 | [125I]-BIM 23027, [125I]-BIM23027 | |||||||
BIO1211 | 6589 | BIO 1211, BIO-1211 | |||||||
bivalirudin | 6470 | Angiomax® | |||||||
BJP-06-005-3 | 11401 | compound 1 [PMID: 32483379], N-(chloroacetyl)-N-methyl-L-phenylalanyl-L-homoprolyl-L-tryptophyl-L-citrulline ethyl ester | |||||||
[3H]BK (human, mouse, rat) | 3812 | [3H]-BK, [3H]-bradykinin | |||||||
blisibimod | 9518 | A-623, AGP3 peptibody, AMG 623, Fc-Agp-3 | |||||||
BM213 | 12513 | ||||||||
BM221 | 12514 | ||||||||
BOC-ATE | 2042 | ||||||||
BODIPY® TMR-NMU | 3858 | ||||||||
bombesin | 616 | ||||||||
BOP | 12045 | compound 2 [PMID: 24363056], compound 3 [PMID: 12033947], N-(Benzenesulfonyl)-L-prolyl-L-O-(1-pyrrolidinylcarbonyl)tyrosine | |||||||
[Bpa1,Ile13]motilin (human) | 1452 | ||||||||
[Bpa6,Tyr10]secretin-27 (rat) | 1154 | ||||||||
BP-CCL3 | 752 | BP-LD78α, BP-MIP-1α, photoactivatable macrophage inflammatory protein-1α | |||||||
BPTI-K15R/R17G | 7897 | ||||||||
BQ123 | 997 | BQ 123, BQ-123 | |||||||
BQ 3020 | 3859 | BQ-3020, BQ3020 | |||||||
[125I]BQ3020 | 1005 | [125I]-BQ3020 | |||||||
[3H]BQ123 | 1003 | [3H]-BQ123, [3H]cyc(DTrp-DAsp-Pro-DVal-Leu | |||||||
bremelanotide | 10408 | PT-141, PT141, Vyleesi® | |||||||
brimapitide | 9101 | AM-111, D-JNKI-1, XG-102 | |||||||
B-R13/17K H2 relaxin | 4371 | AT-001, B13/17K H2 relaxin | |||||||
BT7480 | 12060 | BCY11863, BT-7480 | |||||||
bulevirtide | 12775 | BLV, formerly Myrcludex B, Hepcludex® | |||||||
α-bungarotoxin | 3964 | ||||||||
[125I]α-bungarotoxin | 3972 | ||||||||
[3H]α-bungarotoxin | 3981 | ||||||||
buserelin | 3860 | buserelin acetate, HOE 766, HOE 766A, ICI 123215, Metrelef®, Suprefact® | |||||||
[125I]buserelin | 1167 | [125I]-buserelin | |||||||
Bv8 | 5362 | Bombina variegata protein | |||||||
[Bz-Phe6]U-II (human) | 2159 | human [Bz-Phe6] urotensin-II | |||||||
C | Back to top | ||||||||
C089 | 5779 | ||||||||
C21 | 7037 | ||||||||
C3 | 1291 | ||||||||
C7 | 3861 | galanin(1-13)spantide | |||||||
C5a hexapeptide analogue | 5768 | Phe-Lys-Ala-dCha-Cha-dArg | |||||||
[125I]C3a (human) | 3773 | [125I]-C3a | |||||||
[125I]C5a (human) | 3774 | [125I]-C5a | |||||||
calciseptine | 4149 | ||||||||
calcitonin (salmon) | 6973 | CT (salmon), Miacalcin® | |||||||
calpeptin | 11643 | benzylcarbonyl-Leu-nLeu-H, N-benzyloxycarbonyl-L-leucyl-L-norleucinal | |||||||
cANF4-23 | 4892 | des[Gln18,Ser19,Gly20,Leu21,Gly22]ANP4ï¾–23-NH2 | |||||||
cangitoxin II | 7568 | cangitoxin-2, cangitoxin-II, CGTX-II | |||||||
C5apep | 11344 | ||||||||
carbetocin | 11169 | Pabal® | |||||||
casoxin C | 10224 | ||||||||
[125I]cathepsin G (human) | 1017 | [125I]cathepsin G | |||||||
CB-182804 | 11003 | CB-182,804, CB182804 | |||||||
CCK-58 {Sp: Dog} | 862 | ||||||||
[3H]CCK-8 (human, mouse, rat) | 4765 | [3H]-CCK-8 | |||||||
[125I]CCL11 (human) | 794 | [125I]eotaxin | |||||||
[125I]CCL16 (human) | 1275 | [125I]LEC | |||||||
[125I]CCL17 (human) | 3652 | [125I]TARC | |||||||
[125I]CCL19 (human) | 3655 | [125I]ELC | |||||||
[125I]CCL1 (human) | 814 | [125I]I-309, [125I]P500, [125I]TCA-3 | |||||||
[125I]CCL20 (human) | 3654 | [125I]LARC, [125I]MIP-3α | |||||||
[125I]CCL21 (human) | 3656 | [125I]SLC | |||||||
[125I]CCL25 (human) | 3657 | [125I]TECK | |||||||
[125I]CCL27 (human) | 3653 | [125I]CTACK | |||||||
[125I]CCL2 (human) | 762 | [125I]MCAF, [125I]MCP-1, [125I]monocyte chemotactic protein-1 | |||||||
[125I]CCL3 (human) | 763 | [125I]macrophage inflammatory protein-1α, [125I]MIP-1α | |||||||
[125I]CCL4 (human) | 799 | [125I]macrophage inflammatory protein-1β, [125I]MIP-1β | |||||||
[125I]CCL5 (human) | 764 | [125I]RANTES, [125I]regulated upon activation normal T cell expressed and secreted | |||||||
[125I]CCL7 (human) | 765 | [125I]MCP-3, [125I]monocyte chemotactic protein-3 | |||||||
[125I]CCL8 (human) | 766 | [125I]MCP-2, [125I]monocyte chemotactic protein-2 | |||||||
[125I]CCL1 (mouse) | 5546 | ||||||||
CCL20-SEAP(His)6 | 809 | LARC fused with secreted alkaline phosphatase, LARC-SEAP(His)6, MIP-3α fused with secreted alkaline phosphatase | |||||||
cenderitide | 9066 | CD-NP | |||||||
cetrorelix | 1190 | Cetrotide®, SB-075 | |||||||
[125I]cetrorelix | 1186 | ||||||||
CGEN-856 | 7041 | P61 | |||||||
CGEN-857 | 7040 | P33 | |||||||
CGEN-855A | 6241 | ||||||||
CGP 23996 | 2005 | CGP-23996, CGP23996 | |||||||
CGP42112 | 3944 | CGP 42112, CGP 42112A | |||||||
[125I]CGP 23996 | 2022 | ||||||||
[125I]CGP42112 | 594 | [125I]-CGP42112, Cgp 42112B, Cgp-42112A | |||||||
α-CGRP-(8-37) (human) | 700 | α-CGRP (8-37) (human), human α-calcitonin gene-related peptide (8-37) | |||||||
[125I]αCGRP (human) | 3766 | [125I]-αcalcitonin gene-related peptide, [125I]-αCGRP | |||||||
[125I]αCGRP (mouse, rat) | 6567 | ||||||||
α-CGRP-(8-37) (rat) | 701 | α-CGRP (8-37) (rat), rat α-calcitonin gene-related peptide (8-37) | |||||||
CH 275 | 2006 | CH-275, desAA1,2,5[D-Trp8,IAmp9]somatostatin-14 | |||||||
charybdotoxin | 2328 | ChTX | |||||||
charybdotoxin-GLU32 analog | 2329 | ChTX-GLU32 | |||||||
[Cha6]U-II-(4-11) | 9439 | ||||||||
chemerin C-terminal peptide | 3422 | bioactive chemerin peptide, chemerin 149-157, chemerin 9, chemerin-9 | |||||||
CHIPS | 3724 | chemotaxis inhibitory protein of S. aureus | |||||||
CHIPS-(28-149) | 5770 | CHIPS28-149 | |||||||
[125I]CHIPS | 1027 | [125I]chemotaxis inhibitory protein of S. aureus | |||||||
[(CH2NH)4,5]secretin | 3755 | [ψ4,5]secretin | |||||||
[125I]chorionic gonadotropin (human) | 3775 | [125I]CG (human), [125I]-CG, [125I]-chorionic gonadotropin | |||||||
cibinetide | 9677 | ARA 290, ARA-290, PH-BSP, PHBSP | |||||||
C12-iE-DAP | 9508 | ||||||||
cilengitide | 6597 | EMD-12192, EMD-121974 | |||||||
4-Cl-cinnamoyl-c[DCys-4Pal-DTrp-Orn-Val-Cys]-His-amide | 2161 | ||||||||
[125I]CNP (human) | 4847 | [125I]-CNP | |||||||
C2-NPY (pig) | 1534 | ||||||||
compound 54 | 11898 | ||||||||
compound 6b [PMID: 24999562] |